Skip to content
  • About Us
    • Who We Are
  • Science
    • Prescription Digital Therapeutics
    • Product Pipeline
    • Clinical Trials
    • Research
  • Products
    • reSET® & reSET-O®
    • Somryst®
  • News
    • Press Releases
    • Pear in the News
    • Pear Prescription Digital Therapeutics (PDT) Digest
  • Investors
  • Careers
    • Our Values
    • Our Culture
    • Open Positions
Contact Us
Pear Therapeutics (US)

Press Releases

Media Contact

news@peartherapeutics.com

Press Releases

  • Pear Therapeutics Files for Chapter 11 and Will Seek to Sell Assets Through Sales Process April 7, 2023
  • Pear Therapeutics Announces Process Exploring Strategic Alternatives March 17, 2023
  • Pear Therapeutics to Participate in 43rd Annual Cowen Healthcare Conference February 27, 2023
  • Pear Therapeutics to Participate in the 2023 BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference February 2, 2023
  • Pear Therapeutics and BrightView Health Expand Pilot Program to Provide Prescription Digital Therapeutics for the Treatment of Substance Use Disorders January 26, 2023
  • Pear Therapeutics Announces Inclusion of reSET® and reSET-O® on the January 2023 Florida Medicaid Preferred Drug List January 18, 2023
More
Pear Therapeutics (US)
  • Boston
    200 State Street
    Boston, MA 02109
  • San Francisco
    201 Mission Street
    San Francisco, CA 94105
  • Email Us
  • © 2023 Pear Therapeutics (US), Inc. All Rights Reserved.
  • Privacy Policy
  • Code of Conduct
  • Insider Trading Policy